d1000 Varejo Farma Participações (DMVF3) Stock Overview
Engages in the retail sale of pharmaceutical and perfumery products in Brazil. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
DMVF3 Community Fair Values
See what others think this stock is worth. Follow their fair value or set your own to get alerts.
d1000 Varejo Farma Participações S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$6.08 |
| 52 Week High | R$6.80 |
| 52 Week Low | R$4.28 |
| Beta | 0.14 |
| 1 Month Change | 26.40% |
| 3 Month Change | 40.74% |
| 1 Year Change | 1.33% |
| 3 Year Change | 68.89% |
| 5 Year Change | -47.22% |
| Change since IPO | -60.98% |
Recent News & Updates
Optimistic Investors Push d1000 Varejo Farma Participações S.A. (BVMF:DMVF3) Shares Up 26% But Growth Is Lacking
Dec 05These 4 Measures Indicate That d1000 Varejo Farma Participações (BVMF:DMVF3) Is Using Debt Extensively
Dec 02Why d1000 Varejo Farma Participações' (BVMF:DMVF3) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 06d1000 Varejo Farma Participações (BVMF:DMVF3) Shareholders Will Want The ROCE Trajectory To Continue
Nov 01Recent updates
Shareholder Returns
| DMVF3 | BR Consumer Retailing | BR Market | |
|---|---|---|---|
| 7D | -3.5% | -4.5% | -2.5% |
| 1Y | 1.3% | -5.7% | 11.1% |
Return vs Industry: DMVF3 exceeded the BR Consumer Retailing industry which returned -1.4% over the past year.
Return vs Market: DMVF3 underperformed the BR Market which returned 13.6% over the past year.
Price Volatility
| DMVF3 volatility | |
|---|---|
| DMVF3 Average Weekly Movement | 6.7% |
| Consumer Retailing Industry Average Movement | 6.3% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in BR Market | 9.6% |
| 10% least volatile stocks in BR Market | 2.1% |
Stable Share Price: DMVF3's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: DMVF3's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 4,500 | Sammy Birmarcker | www.d1000varejofarma.com.br/ri |
d1000 Varejo Farma Participações S.A. engages in the retail sale of pharmaceutical and perfumery products in Brazil. It also sells generic drugs, and hygiene and beauty products. The company was formerly known as Cancun RJ Participações S/A and changed its name to d1000 Varejo Farma Participações S.A. in March 2016.
d1000 Varejo Farma Participações S.A. Fundamentals Summary
| DMVF3 fundamental statistics | |
|---|---|
| Market cap | R$307.67m |
| Earnings (TTM) | R$16.66m |
| Revenue (TTM) | R$2.60b |
Is DMVF3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DMVF3 income statement (TTM) | |
|---|---|
| Revenue | R$2.60b |
| Cost of Revenue | R$1.87b |
| Gross Profit | R$730.70m |
| Other Expenses | R$714.04m |
| Earnings | R$16.66m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.33 |
| Gross Margin | 28.13% |
| Net Profit Margin | 0.64% |
| Debt/Equity Ratio | 6.3% |
How did DMVF3 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/10 18:41 |
| End of Day Share Price | 2025/12/09 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
d1000 Varejo Farma Participações S.A. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Georgia Jorge | BB Banco de Investimento S.A. |
| Jennie Li | XP Investimentos |
